Insider Transactions in Q2 2025 at Phreesia, Inc. (PHR)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 16
2025
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
4,499
-1.02%
|
$103,477
$23.74 P/Share
|
|
Apr 16
2025
|
Yvonne Hui Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
418
-1.65%
|
$9,614
$23.66 P/Share
|
|
Apr 16
2025
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,091
-0.25%
|
$71,093
$23.81 P/Share
|
|
Apr 16
2025
|
Evan Roberts Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,845
-0.24%
|
$42,435
$23.81 P/Share
|
|
Apr 16
2025
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
624
-0.48%
|
$14,352
$23.81 P/Share
|
|
Apr 16
2025
|
Balaji Gandhi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
864
-0.8%
|
$19,872
$23.81 P/Share
|
|
Apr 16
2025
|
Allison C Hoffman General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
1,213
-0.87%
|
$27,899
$23.81 P/Share
|
|
Apr 15
2025
|
Yvonne Hui Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
314
-1.22%
|
$7,536
$24.04 P/Share
|
|
Apr 09
2025
|
Allison C Hoffman General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
4,696
-3.27%
|
$108,008
$23.23 P/Share
|
|
Apr 09
2025
|
Yvonne Hui Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,802
-9.85%
|
$64,446
$23.23 P/Share
|
|
Apr 08
2025
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Indirect |
248
-1.35%
|
$5,704
$23.97 P/Share
|
|
Apr 08
2025
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
3,944
-0.88%
|
$90,712
$23.97 P/Share
|
|
Apr 08
2025
|
Allison C Hoffman General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
6,024
-2.03%
|
$138,552
$23.97 P/Share
|
|
Apr 08
2025
|
Yvonne Hui Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,878
-3.14%
|
$43,194
$23.97 P/Share
|
|
Apr 08
2025
|
Evan Roberts Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
7,233
-0.46%
|
$166,359
$23.97 P/Share
|
|
Apr 08
2025
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
1,695
-0.64%
|
$38,985
$23.97 P/Share
|
|
Apr 08
2025
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
12,167
-0.48%
|
$279,841
$23.97 P/Share
|
|
Apr 08
2025
|
Balaji Gandhi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,045
-3.51%
|
$185,035
$23.97 P/Share
|
|
Apr 04
2025
|
Balaji Gandhi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,865
+9.95%
|
-
|
|
Apr 04
2025
|
Yvonne Hui Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,680
+13.37%
|
-
|
|
Apr 04
2025
|
Allison C Hoffman General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
10,720
+6.68%
|
-
|
|
Apr 04
2025
|
Amy Beth Van Duyn SVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
3,752
+2.76%
|
-
|
|
Apr 04
2025
|
Chaim Indig Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,085
+1.71%
|
-
|
|
Apr 04
2025
|
David Linetsky SVP, Life Sciences |
BUY
Grant, award, or other acquisition
|
Indirect |
536
+5.47%
|
-
|
|
Apr 04
2025
|
David Linetsky SVP, Life Sciences |
BUY
Grant, award, or other acquisition
|
Direct |
6,432
+2.77%
|
-
|
|
Apr 04
2025
|
Evan Roberts Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,865
+1.61%
|
-
|